In this article, we will discuss Ken Fisher’s top growth stocks.
Ken Fisher is the founder and executive chairman of Fisher Asset Management, a renowned investment and financial analysis expert. He established the firm in 1979 and now has $299 billion in assets under management. Over the years, he has built a legacy of innovative investment strategies, a contrarian approach, and a focus on long-term growth.
Investment Philosophy and Strategies of Fisher:
Compared with many other firms, Fisher Investments’ most distinctive aspects are its methodical approach to portfolio management and its reliance on research. In his 1984 book Super Stocks, he popularized the Price-to-Sales (P/S) ratio to find undervalued growth stocks. The ratio continues to play a key role in his firm’s stock selection process, helping to uncover companies with strong growth prospects that might be hidden from the broader market.
Fisher’s contrarian mentality distinguishes him from most investors. He advises questioning mainstream market sentiments and looking for opportunities others might miss. His book The Only Three Questions That Count examines this more in-depth, explaining how good investors must constantly challenge their view of the world, find insights no one else sees, and combat mental biases to find the right investment opportunity.
Diversified Portfolio and Sector Emphasis:
The firm’s holdings express Fisher’s long-held maxim that diversification helps reduce risk. Technology is a particularly strong-performing sector, accounting for 31.8% of the portfolio as of Q3 2024, displaying Fisher’s faith in the enduring rise of tech stocks. The portfolio is also heavy in other sectors, such as services (14.6%), financial services (12.3%), and healthcare (10.5%).
In 2024, Fisher Investments achieved an incredible 32.18% return, fueled mainly by its tech positions, especially in companies that benefited from the artificial intelligence boom. While many investors have become cautious about frothy tech valuations, Fisher’s firm has remained steadfast, doubling down on AI chipmakers and other tech innovators.
Recent Developments:
In January 2025, Fisher Investments finalized the sale of a minority stake valued at nearly $3 billion to Advent International and the Abu Dhabi Investment Authority, valuing the firm at approximately $13 billion. The decision is a strategic move that has been a part of Ken Fisher’s long-term estate planning, allowing the firm to continue its private independence and never-ending commitment to outstanding client service. Given this, we will take a look at some of the best high growth stocks in Ken Fisher’s portfolio.
Our Methodology
To analyze Billionaire Ken Fisher’s Top 10 High Growth Stock Picks, we began by reviewing the largest positions in Fisher Asset Management’s portfolio as of Q3 2024. We focused on identifying stocks with trailing twelve-month (TTM) revenue growth of at least 20% compared to 2023, as this growth metric highlights companies demonstrating robust expansion. We then picked the first ten stocks that met the growth criteria, providing a clear overview of high-growth opportunities in the portfolio.
At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).
10. Wynn Resorts, Limited (NASDAQ:WYNN)
Net revenue growth in the past 12 months: 25.16%
Wynn Resorts, Limited (NASDAQ:WYNN) is a luxury hospitality and gaming company that develops, owns, and operates high-end destination casino resorts. The company’s iconic properties are renowned for their luxurious amenities, upscale entertainment offerings, and world-class service.
Strategically, Wynn Resorts, Limited (NASDAQ:WYNN) is expanding its global footprint. In January 2025, the company announced plans to acquire Crown London Aspinalls, a prestigious members-only casino located in London’s Mayfair district. This acquisition, pending regulatory approvals expected in the second half of 2025, marks Wynn’s entry into the UK market and aligns with its strategy to expand its presence in Europe and the Middle East.
Wynn Resorts, Limited (NASDAQ:WYNN) reported operating revenues of $1.69 billion for the third quarter of 2024, marking a 1.2% increase from $1.67 billion in the same period of 2023. The net loss attributable to Wynn Resorts was $32.1 million for the third quarter of 2024, an improvement compared to a net loss of $116.7 million for the third quarter of 2023.
The stock constitutes 0.15% of Fisher’s portfolio. As of the close Q3 2024, Fisher Asset Management had over 3.9 million shares in Wynn Resorts, Limited (NASDAQ:WYNN), worth more than $380.8 million. During the quarter, the hedge fund increased its position in the company significantly by 71%.
9. Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA)
Net revenue growth in the past 12 months: 27.08%
Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) is a multinational financial services company based in Spain, offering banking, insurance, and asset management services in several countries.
On October 31, 2024, Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) reported strong financial results for the first nine months of 2024, achieving a net attributable profit of $8.3 billion, a 27.9% increase compared to the same period in 2023. This growth was driven by a 5.7% rise in net interest income to $20.5 billion and supported by the bank’s investments in technology and expansion, despite a 10.3% increase in operating expenses to $11.1 billion.
Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) diversified operations in Spain, Mexico, Turkey, and South America contributed to these results, with profit increases of 37.6% in Spain and 5.6% in Mexico. Additionally, the bank prioritized shareholder value, paying its highest-ever dividend of $0.31 per share on October 10, 2024—an 81% increase from the prior year.
Fisher Asset Management reduced its total position in BBVA by 2% during Q3 2024 but still owns 50.9 million shares worth $552.3 million. The stock represented 0.22% of the hedge fund’s total 13F portfolio.
8. Las Vegas Sands Corp. (NYSE:LVS)
Net revenue growth in the past 12 months: 31.99%
Las Vegas Sands Corp. (NYSE:LVS) is a leading global developer and operator of integrated resorts and casinos. The company manages iconic properties such as Marina Bay Sands in Singapore and The Venetian in Las Vegas, offering luxury accommodations, entertainment, retail, and convention facilities.
In the third quarter of 2024, Las Vegas Sands Corp. (NYSE:LVS) reported mixed financial results. Net revenue fell 4% year-over-year to $2.68 billion, missing analysts’ expectations of $2.79 billion. Earnings per share came in at $0.44, below the anticipated $0.53. The company’s performance was negatively impacted by ongoing renovations at its Londoner casino in Macao and a 14% decline in per-table income in Singapore, which dropped from $698 million to $600 million compared to the same quarter in 2023.
Despite these short-term challenges, Las Vegas Sands Corp. (NYSE:LVS) is focused on driving long-term growth through strategic investments. The company announced an $8 billion expansion plan for Marina Bay Sands in Singapore, including a fourth hotel tower with luxury suites and a 15,000-seat arena.
On January 3, 2025, Jefferies upgraded Las Vegas Sands Corp. (NYSE:LVS) to a “Buy,” reflecting confidence in its strategic investments and future growth potential.
7. ServiceNow, Inc. (NYSE:NOW)
Net revenue growth in the past 12 months: 23.48%
ServiceNow, Inc. (NYSE:NOW) is a leading American software company offering a cloud-based platform for managing digital workflows in global enterprises. It helps organizations streamline operations, improve efficiency, and enhance the user experience by providing a unified interface for managing tasks, services, and processes.
ServiceNow, Inc. (NYSE:NOW)’s standout innovation, the Now Assist AI, has emerged as its fastest-growing product. With accelerated adoption, 44 customers now contribute over $1 million in annual contract value (ACV). Among these, six deals exceeded $5 million, and two surpassed $10 million in ACV.
In its recent financial results, ServiceNow, Inc. (NYSE:NOW) reported robust third-quarter performance. Total revenue grew 22% year-over-year (YoY) to $2.8 billion, with subscription revenues—a major component—rising 22.5% to $2.72 billion.
Piper Sandler raised the target price for ServiceNow, Inc. (NYSE:NOW) on January 6, 2025, from $1,000 to $1,200, maintaining an “Overweight” rating and projecting an 11% upside from the current price level.
6. Novo Nordisk A/S (NYSE:NVO)
Net revenue growth in the past 12 months: 26.15%
Novo Nordisk A/S (NYSE:NVO), a global leader in healthcare specializing in treatments for chronic diseases like diabetes, obesity, hemophilia, and growth disorders, has recently faced market volatility. The company’s stock declined approximately 20% following clinical trial results for its obesity drug, CagriSema. The trial showed a weight reduction of 22.7%, slightly below the expected 25%, which caused investor concerns. Despite this temporary setback, the company remains well-positioned in its market.
In January 2025, Novo Nordisk (NYSE:NVO) expanded its partnership with Valo Health. This collaboration integrates human health data and AI technology to accelerate the development of new treatments for obesity, type 2 diabetes, and heart disease. Novo Nordisk committed $190 million in initial payments, with potential milestone-based payouts totaling up to $4.6 billion. This substantial investment highlights the company’s focus on innovation and addressing unmet needs in chronic disease management.
Analysts maintain a positive outlook on Novo Nordisk’s (NYSE:NVO) prospects. UBS Group recently upgraded its rating on the stock from “Sell” to “Buy,” citing confidence in the company’s strategic initiatives and market leadership. The continued investment in partnerships and product portfolio expansion reinforces the company’s resilience and growth potential.
5. JPMorgan Chase & Co. (NYSE:JPM)
Net revenue growth in the past 12 months: 23.99%
JPMorgan Chase & Co. (NYSE:JPM), the largest bank in the United States, offers a broad range of financial services, including deposit accounts, investment products, lending solutions, and investment banking. Operating in over 100 countries, the company continues to demonstrate strong financial performance.
In the third quarter of 2024, JPMorgan Chase & Co. (NYSE:JPM) reported earnings per share of $4.37, surpassing the consensus estimate of $4.02. Net revenue for the quarter reached $42.7 billion, exceeding analysts’ expectations of $41.4 billion. Assets under management increased by 23% to $3.9 trillion, while investment banking revenue grew 29% year-over-year to $2.4 billion. Over the past year, the company’s stock price has risen more than 41%, outperforming the broader market’s 24% gain.
JPMorgan Chase & Co. (NYSE:JPM) has made notable strategic moves, such as hiring top talent like Stuart Jempson from Barclays to strengthen its UK dealmaking team. However, its departure from the Net-Zero Banking Alliance underscores the challenges of balancing regulatory and environmental commitments.
As of Q3 2024, Fisher Asset Management owned 16.8 million shares of JPMorgan Chase & Co. (NYSE:JPM), valued at $3.54 billion. The company accounted for 1.45% of the hedge fund’s total 13F portfolio.
4. Meta Platforms, Inc. (NASDAQ:META)
Net revenue growth in the past 12 months: 23.06%
Meta Platforms, Inc. (NASDAQ:META) is a leading technology company specializing in social media, virtual reality (VR), and artificial intelligence (AI). The company operates a suite of widely used platforms, including Facebook, Instagram, WhatsApp, and Oculus, designed to connect people and enable immersive digital experiences.
On January 8, 2025, CEO Mark Zuckerberg announced the replacement of Meta’s fact-checking program on Facebook and Instagram with a “Community Notes” feature, modeled after a similar system used by X (formerly Twitter). The change is designed to reduce errors, streamline policies, and promote free speech across its platforms.
In Q3 2024, Meta Platforms, Inc. (NASDAQ:META) reported a 19% year-over-year revenue increase, reaching $40.6 billion, driven largely by advertising revenue of $39.9 billion (an 18.7% rise). These results were boosted by AI-driven enhancements in content recommendations and ad targeting, which led to a 7% increase in ad impressions and an 11% rise in average ad price.
Meta Platforms, Inc. (NASDAQ:META)’s adoption of advanced AI technologies has also spurred higher user engagement, with over 500 million users interacting with its chat assistant across applications. New products such as the Threads app and the Llama 2 AI model have further diversified its portfolio. Threads, in particular, has grown to nearly 275 million monthly active users, with over 1 million daily sign-ups, highlighting strong user adoption.
To support these initiatives, Meta’s capital expenditures are projected to rise to $53.4 billion in 2025. These investments are essential to sustain growth in AI-driven services and new product development.
Jefferies analysts recently raised their price target for Meta Platforms, Inc. (NASDAQ:META) to $715, citing its potential as a leader in consumer AI technologies.
3. Broadcom Inc. (NASDAQ:AVGO)
Net revenue growth in the past 12 months: 43.99%
Broadcom Inc. (NASDAQ:AVGO) is a leading multinational technology company specializing in semiconductor and infrastructure software products. The company has projected significant growth in its AI-related revenue, estimating a serviceable addressable market of $60–90 billion by fiscal 2027, up from $12.2 billion in fiscal 2024. This growth is driven by partnerships with major hyperscalers like Google, Meta Platforms, and ByteDance.
In Q4 of fiscal 2024, Broadcom Inc. (NASDAQ:AVGO) reported a 51% year-over-year revenue increase, reaching $14.05 billion, alongside a 28% rise in adjusted earnings per share to $1.42. The company expects this momentum to continue, projecting revenues of $14.6 billion in Q1 of fiscal 2025.
The successful integration of VMware, acquired in November 2023, has bolstered Broadcom’s infrastructure software segment, diversifying its revenue streams and strengthening its market position.
UBS analyst Timothy Arcuri recently raised his price target for Broadcom Inc. (NASDAQ:AVGO) to $270 from $220, citing confidence in the company’s AI-driven growth potential. Revenue forecasts for fiscal years 2026 and 2027 have also been increased to reflect the strong outlook.
2. Eli Lilly and Company (NYSE:LLY)
Net revenue growth in the past 12 months: 27.41%
Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical powerhouse renowned for pioneering advancements in therapeutic areas such as diabetes, oncology, neuroscience, and immunology.
Eli Lilly and Company (NYSE:LLY) reported robust financial performance in Q3 2024, with revenue surging 20% year-over-year to $11.44 billion, driven by the strong performance of its GLP-1 drugs, Mounjaro and Zepbound. These medications have significantly bolstered the company’s foothold in the weight-loss drug market, contributing substantially to revenue growth.
The company has also made strides in expanding its portfolio and market reach. Eli Lilly and Company (NYSE:LLY) is in advanced negotiations to acquire cancer-focused biotech Scorpion Therapeutics for up to $2.5 billion. This move aims to diversify its pipeline with promising oncology treatments, signaling a strategic focus on strengthening its presence in the cancer treatment space.
Additionally, Eli Lilly and Company (NYSE:LLY)’s Zepbound recently received FDA approval for treating obstructive sleep apnea in obese patients. This approval allows Medicare Part D plans to cover the drug for this specific use, potentially generating over 3.7 million new prescriptions annually. This regulatory milestone could significantly increase the drug’s market potential.
Eli Lilly and Company (NYSE:LLY) is also bolstering its manufacturing capacity with a $3 billion investment in a newly acquired facility in Kenosha County, Wisconsin, to support its growing pipeline and meet increased demand for its innovative therapies.
1. NVIDIA (NASDAQ:NVDA)
Net revenue growth in the past 12 months: 152.44%
Nvidia Corporation (NASDAQ:NVDA) is a global leader in advanced computing technologies, specializing in the design and development of graphics processing units (GPUs), system-on-a-chip units (SoCs), and cutting-edge software solutions. Its innovations power a broad range of applications, from gaming and professional visualization to data centers and artificial intelligence (AI). As a pioneer in GPU-driven computing, Nvidia has become a cornerstone of industries that rely on high-performance graphics, AI-driven insights, and scalable computing power.
Nvidia Corporation (NASDAQ:NVDA) delivered a record-breaking performance in Q3 fiscal 2025, achieving revenue of $35.1 billion. This represents a 17% increase from the prior quarter and a 94% year-over-year surge, largely driven by Data Center revenue growth of 112% YoY to $30.8 billion.
At the Consumer Electronics Show (CES) 2025, CEO Jensen Huang unveiled the GeForce RTX 50 Series GPUs, powered by the Blackwell AI chip, to elevate gaming experiences and support advanced AI applications. Nvidia also introduced Project Digits, a personal AI supercomputer priced at $3,000, aimed at democratizing AI access, alongside Nvidia Cosmos, an advanced AI model designed for robotics and industrial AI uses.
In 2024, Nvidia Corporation (NASDAQ:NVDA) invested $1 billion in AI start-ups and corporate deals, up from $872 million the previous year, reflecting its dedication to fostering a robust AI ecosystem.
Fisher Asset Management increased its position in Nvidia Corporation (NASDAQ:NVDA) by 4% last quarter, bringing its total holdings to 96.7 million shares, accounting for 4.81% of the firm’s 13F portfolio.
Overall Nvidia Corporation (NASDAQ:NVDA) ranks first on our list of Ken Fisher’s top growth stocks. While we acknowledge the potential of NVDA as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NVDA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
